Please assess the completion status of the following clinical trial:

Trial Title: A Double-blind, Randomized, Parallel Design Study to Compare the Effectiveness of Sugammadex Versus Neostigmine in Improving Surgical Condition in Subjects Undergoing Laryngeal Microsurgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients of age over 20 years~* scheduled for laryngeal microsurgery under general anesthesia~Exclusion Criteria:~* anticipated difficult intubation, cervical spine disease, neuromuscular disease, acute or chronic renal failure, liver cirrhosis or liver failure~* history of allergy to nondepolarizing muscle relaxant~* history of malignant hyperthermia~* pregnant woman~* body mass index over 35 kg/m2

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Neostigmine arm (Type: EXPERIMENTAL): Neostigmine arm
- Sugammadex arm (Type: ACTIVE_COMPARATOR): Sugammadex arm

Based on this trial design, predict the completion outcome and termination type (if applicable).